RQ759893 - Model B31-102 Needleless Injections

The District of Columbia has issued a procurement opportunity (RQ759893) for Model B31-102 Needleless Injections, with a solicitation posted on January 10, 2012, and a proposal submission deadline of January 18, 2012. This procurement appears to be focused on acquiring specialized medical supplies, specifically needleless injection equipment, for government healthcare operations. The contract seeks vendors capable of providing high-quality medical injection devices that eliminate traditional needle-based injection methods, potentially improving patient safety and reducing infection risks. The procurement requires vendors to demonstrate comprehensive technical specifications, compliance with medical device regulations, and the ability to supply Model B31-102 units that meet stringent healthcare standards. Potential bidders must carefully review all technical requirements and submit detailed proposals that comprehensively address the specific model's characteristics, performance capabilities, and adherence to District of Columbia healthcare procurement guidelines.

While specific set-aside designations are not explicitly detailed in the provided information, government medical supply contracts often include provisions for disadvantaged business enterprises or local small business participation. The procurement appears to be open to medical equipment manufacturers and distributors with proven track records in supplying needleless injection technologies. Given the specialized nature of the procurement, vendors will likely need demonstrated expertise in medical device manufacturing, regulatory compliance, and healthcare supply chain management. The contract's potential award value is not specified, but medical equipment procurement for municipal healthcare systems typically ranges from moderate to significant financial investments. Interested vendors should prepare comprehensive proposals that highlight technical specifications, pricing structures, delivery capabilities, and any value-added services that distinguish their offerings in the competitive medical supply market.